ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health disparities"

  • Abstract Number: 1958 • 2016 ACR/ARHP Annual Meeting

    Effect of Poverty Status in 2009, % of Years in Poverty Between 2003 and 2009, and Exiting Poverty Permanently By 2009 on SLE Damage in 2015

    Edward H. Yelin1, Jinoos Yazdany2 and Laura Trupin3, 1Medicine/Rheumatology, UC San Francisco, San Francisco, CA, 2Rheumatology, University of California, San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California San Francisco, San Francisco, CA

    Background/Purpose : The relationship between poverty and SLE damage has been observed in several cross-sectional studies. The aim of the present study was to use…
  • Abstract Number: 1968 • 2016 ACR/ARHP Annual Meeting

    Adverse Childhood Experiences and Outcomes of Systemic Lupus Erythematosus

    Laura Trupin1, Patricia P. Katz1, Cristina Lanata1, Edward H. Yelin1, Lindsey A. Criswell1, Charles G. Helmick2, Jinoos Yazdany1 and Maria Dall'Era1, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA

    Background/Purpose: Adverse childhood experiences such as extreme deprivation, neglect, abuse, parental separation or incarceration, have been associated with adult health status, including onset of rheumatic…
  • Abstract Number: 1971 • 2016 ACR/ARHP Annual Meeting

    Predictors of Delays to Care and Associated Outcomes in Pediatric Lupus Patients from the Childhood Arthritis and Rheumatology Research Alliance Registry

    Tamar Rubinstein1,2, Norman Ilowite3,4 and Dawn Wahezi5,6, 1Division of Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, 2Pediatric Rheumatology, Children's Hospital at Montefiore, Bronx, NY, 3Division of Pediatric Rheumatology, Children's Hospital at Montefiore, Bronx, NY, 4Pediatrics, Albert Einstein College of Medicine, Bronx, NY, 5Pediatric Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 6Pediatric Rheumatology, The Children's Hospital at Montefiore, Bronx, NY

    Background/Purpose:  CARRA registry data for participants meeting ACR classification criteria for lupus were analyzed. Delays of one month, 3 months, and one year from symptom…
  • Abstract Number: 406 • 2015 ACR/ARHP Annual Meeting

    Long Term Follow up of Inner City Pediatric Patients with Lupus Nephritis

    Janice Desir1, Beatrice Goilav2, Ellen Silver3 and Irene Blanco4, 1Pediatric Nephrology, Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, NY, 2Division of Nephrology, Children's Hospital at Montefiore, Bronx, NY, 3Pediatrics, Albert Einstein College of Medicine, Bronx, NY, 4Medicine, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: In children with SLE, 80% have renal involvement, which is a major prognostic factor for both morbidity and mortality. Few studies have focused on…
  • Abstract Number: 1092 • 2015 ACR/ARHP Annual Meeting

    Illicit Drug Use in US Adults with Chronic Low Back Pain: Nhanes 2009-2010

    Anna Shmagel1 and Robert Foley2, 1Rheumatic & Autoimmune Diseases, University of Minnesota Medical School, Minneapolis, MN, 2Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN

    Background/Purpose: Addictive medications, such as opiates and benzodiazepines are frequently prescribed to patients with chronic low back pain (cLBP). Little is known about illicit drug…
  • Abstract Number: 2266 • 2015 ACR/ARHP Annual Meeting

    Is Rheumatic Disease Really More Severe in Indigenous Populations? a Systematic Review of Clinical Outcomes in Indigenous Populations of Canada, the United States, Australia and New Zealand

    Kelle Hurd1 and Cheryl Barnabe2, 1University of Calgary, Calgary, AB, Canada, 2Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

    Background/Purpose: The Indigenous populations of Canada, the United States, Australia and New Zealand have higher disease prevalence for many inflammatory arthritis conditions and connective tissue…
  • Abstract Number: 30 • 2015 ACR/ARHP Annual Meeting

    Complications of Inflammatory Arthritis in First Nations and Non-First Nations Populations of Alberta, Canada

    Cheryl Barnabe1, Gilaad Kaplan2, J Antonio Avina-Zubieta3, Diane Lacaille4, Brenda Hemmelgarn5 and JM Esdaile6, 1Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Division of Gastroenterology, University of Calgary, Calgary, AB, Canada, 3Arthritis Research Canada / University of British Columbia, Vancouver, BC, Canada, 4Arthritis Research Centre, University of British Columbia, Vancouver, BC, Canada, 5Division of Nephrology, University of Calgary, Calgary, AB, Canada, 6Rheumatology, Arthritis Research Canada, Richmond, BC, Canada

    Background/Purpose: With markedly improved control of the acute effects of inflammatory arthritis, the major causes of morbidity and premature death now arise from the complications…
  • Abstract Number: 53 • 2015 ACR/ARHP Annual Meeting

    Associations Between Race and Income Disparity on Morbidity in Juvenile Dermatomyositis

    Kathryn Phillippi1, Mark Hoeltzel2, Angela Byun Robinson3,4, Susan Kim5 and CARRA investigators, 1Pediatric Infectious Diseases and Rheumatology, Rainbow Babies and Children’s Hospital / Case Medical Center, Cleveland, OH, 2Rheumatology Division, University of Michigan Mott Children's Hospital, Ann Arbor, MI, 3Pediatrics, Rainbow Babies & Children's Hospital / Case Medical Center, Cleveland, OH, 4Pediatric Rheumatology, Rainbow Babies and Childrens Hospital, Cleveland, OH, 5Division of Immunology, Boston Children's Hospital, Boston, MA

    Disclosure: T32 grant: the National Institutes of Health under Ruth L. Kirschstein National Research Service Award T32 AR007505 from the NIH NIAMS. The CARRA Registry is…
  • Abstract Number: 1937 • 2014 ACR/ARHP Annual Meeting

    Model Examining Factors Related to Physicians’ Ratings of Disease Activity in Patients with RA

    Julia R. Ayeroff1, Sarah R. Ormseth2, David Hardy3, Michael R. Irwin2, Michael H. Weisman4 and Perry M. Nicassio2, 1Postbaccalaureate Premedical Program, University of Southern California, Los Angeles, CA, 2Cousins Center for PNI, University of California, Los Angeles, Los Angeles, CA, 3Psychology, Loyola Marymount University, Los Angeles, CA, 4Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA

    Background/Purpose: The purpose of this study was to examine a multidimensional, integrated model describing the interrelations among rheumatoid arthritis (RA) objective disease activity, patient-rated disease…
  • Abstract Number: 1088 • 2014 ACR/ARHP Annual Meeting

    Socioeconomic Disparities in Health Outcomes Among Individuals with, or at Risk for, Osteoarthritis from the United States: Data from the Osteoarthritis Initiative

    Antoine A. Baldassari1, Todd Schwartz1, Rebecca J. Cleveland1, Joanne M. Jordan2 and Leigh F. Callahan3, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina Dept of Epidemiology, Chapel Hill, NC, 3Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC

    Background/Purpose Socioeconomic disparities in health outcomes among people with osteoarthritis are well documented, with some key limitations: existing studies limit their analyses to few outcome…
  • Abstract Number: 900 • 2014 ACR/ARHP Annual Meeting

    Race and Sex Specific Incidence Rates and Predictors of Total Knee Arthroplasty: Data from the Osteoarthritis Initiative, 7 Years Follow up

    Jamie E. Collins1, Bhushan Deshpande1, Jeffrey N. Katz2 and Elena Losina1, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Total knee arthroplasty (TKA) is used to reduce pain and improve functional status in persons with symptomatic knee osteoarthritis (OA). Several studies point to…
  • Abstract Number: 1912 • 2013 ACR/ARHP Annual Meeting

    Do Persons With SLE In Poverty Rate Interactions With Providers and Health Plans Differently?

    Edward H. Yelin1, Chris Tonner2, Laura Trupin2 and Jinoos Yazdany3, 1Medicine, UC San Francisco, San Francisco, CA, 2Medicine, University of California, San Francisco, San Francisco, CA, 3Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: We previously showed that poverty is associated with the quantity, type, and technical quality of care in SLE.[1]  Here we assess whether poverty is…
  • Abstract Number: 1195 • 2013 ACR/ARHP Annual Meeting

    Sex Differences In Gout Evaluation and Management

    Leslie R. Harrold1, Carol Etzel2, Allan Gibofsky3, Joel M. Kremer4, Michael H. Pillinger5, Kenneth G. Saag6, Naomi Schlesinger7, Robert Terkeltaub8, Vanessa Cox2 and Jeffrey D. Greenberg9, 1University of Massachusetts Medical School, Worcester, MA, 2CORRONA, Inc, Southborough, MA, 3Medicine and Public Health, Hospital for Special Surgery, New York, NY, 4Center for Rheumatology, Albany Medical College, Albany, NY, 5NYU School of Medicine, Division of Rheumatology, New York, NY, 6Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, 7Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, 8Medicine-Rheumatology, VA Medical Ctr/University of California San Diego, San Diego, CA, 9Departments of Medicine (Rheum Div) and Hospital for Joint Diseases, New York Hospital for Joint Diseases, New York, NY

    Background/Purpose: Little is known regarding the evaluation, characteristics and management of women with gout.  To characterize potential gender differences, we therefore compared clinical manifestations and…
  • Abstract Number: 2511 • 2012 ACR/ARHP Annual Meeting

    Potential Barriers That Limit Access to Rheumatologists Among Patients with Early Rheumatoid Arthritis in a Universal Access Health Care System

    Jessica Widdifield1, J. Michael Paterson2, Sasha Bernatsky3, Karen Tu2, Nadia Gunraj2, Noah Ivers1, Debra Butt2, R. Liisa Jaakkimainen4, J. Carter Thorne5, Vandana Ahluwalia6 and Claire Bombardier7, 1University of Toronto, Toronto, ON, Canada, 2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 3Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, 4Preventive Med and Biostatisti, University of Toronto, Toronto, ON, Canada, 5Southlake Regional Health Centre, Newmarket, ON, Canada, 6William Osler Health Center, Brampton, ON, Canada, 7Rheumatology, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Current guidelines for the optimal care of rheumatoid arthritis (RA) recommend prompt referral to a rheumatologist. In the province of Ontario, Canada all 13…
  • Abstract Number: 947 • 2012 ACR/ARHP Annual Meeting

    The Impact of Dyspigmentation and Scarring in Cutaneous Lupus On Quality of Life

    Saroj M. Verma1, Joyce Okawa2, Kathleen Propert3 and Victoria P. Werth4, 1Dermatology, University of Pennsylvania, Philadelphia, PA, 2Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania and Philadelphia V.A. Medical Center, Philadelphia, PA, 3Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 4Department of Dermatology, Veteran Affairs Medical Center, Philadelphia, PA

    Background/Purpose: Patients with more severe cutaneous lupus activity have poorer quality of life. The main objective of the current study was to evaluate the impact…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology